id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0219-0015,FDA,FDA-2001-D-0219,"Use of Data Monitoring Committees in Clinical Trials; Draft Guidance for Industry; Availability; Agency
Information Collection Activities; Proposed Collection; Comment Request",Notice,Notice of Availability,2024-02-13T05:00:00Z,2024,2,,,2024-02-13T14:42:27Z,2024-02849,0,0,0900006486404168
FDA-2001-D-0219-0016,FDA,FDA-2001-D-0219,Use of Data Monitoring Committees in Clinical Trials; Guidance for Industry; Draft Guidance,Other,Guidance,2024-02-13T05:00:00Z,2024,2,2024-02-13T05:00:00Z,2024-04-16T03:59:59Z,2025-06-06T09:00:07Z,,1,0,0900006486404548